BSE filing, NSE: WAGEND. Summary written from the filing by ALFA Finder's alert engine.
Wagend Infra Venture Ltd: key numbers
- Share price
- ₹1.30
- Market cap
- ₹6.13 Cr
- Revenue (annual)
- ₹2.43 Cr
- Net profit (annual)
- ₹0.03 Cr
- P/E (TTM)
- 155.5×Sector 19.7×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wagend Infra Venture Ltd
All →Wagend Infra Venture Management Change
Wagend Infra Venture Limited has redesignated Mr. Kaushik Kantilal Shah as a Non-Executive Independent Director, effective September 30, 2026.
Wagend Infra Venture Annual General Meeting
Wagend Infra Venture Limited held its 44th Annual General Meeting on September 30, 2026. The meeting covered agenda items including the adoption of financial statements.
Wagend Infra Venture Annual General Meeting
Wagend Infra Venture issued the 44th AGM notice for September 30, 2026. Agenda includes adoption of FY26 accounts and appointment of an Independent Director.
Wagend Infra Venture Annual Report
Wagend Infra Venture has filed its 44th Annual Report for FY 2025-26 with BSE. The report includes the 44th AGM notice scheduled for September 30, 2026.
Wagend Infra Venture Management Change
Wagend Infra Venture Limited appointed Mr. Kaushik Kantilal Shah as a Non-Executive Independent Director, effective August 14, 2026.
Wagend Infra Venture Q1 FY27 Results: Net Profit ₹0 Cr
Wagend Infra Venture Ltd reported revenue from operations of ₹1.3 Cr (+333.3% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.